neurons

Industry

-

Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain

Ion Channel library
About
Credits

artem@ionchannellibrary.com

© 2023 Artem Kondratskyi

Terms of Use

Privacy policy